AAAAAA

   
Results: 1-25 | 26-39
Results: 1-25/39
PROGNOSTIC-SIGNIFICANCE OF ALK ONCOGENE EXPRESSION IN ANAPLASTIC LARGE-CELL LYMPHOMA (ALCL)
Authors: GASCOYNE RD WU CD CHHANABHAI M MORRIS SW PULFORD K MASON D GREINER TC CONNORS JM VOSE JM COLDMAN A WEISENBURGER DD
Citation: Rd. Gascoyne et al., PROGNOSTIC-SIGNIFICANCE OF ALK ONCOGENE EXPRESSION IN ANAPLASTIC LARGE-CELL LYMPHOMA (ALCL), Modern pathology, 11(1), 1998, pp. 129-129
STATISTICAL EVALUATION OF DIAGNOSTIC AND PROGNOSTIC FEATURES OF CD30-A CLINICOPATHOLOGICAL STUDY OF 65 CASES( CUTANEOUS LYMPHOPROLIFERATIVE DISORDERS )
Authors: VERGIER B BEYLOTBARRY M PULFORD K MICHEL P BOSQ J DEMURET A BEYLOT C DELAUNAY MM AVRIL MF DALAC S BODEMER C JOLY P GROPPI A DEMASCAREL A BAGOT M MASON DY WECHSLER J MERLIO JP
Citation: B. Vergier et al., STATISTICAL EVALUATION OF DIAGNOSTIC AND PROGNOSTIC FEATURES OF CD30-A CLINICOPATHOLOGICAL STUDY OF 65 CASES( CUTANEOUS LYMPHOPROLIFERATIVE DISORDERS ), The American journal of surgical pathology, 22(10), 1998, pp. 1192-1202
COEXPRESSION OF CD79A (JCB117) AND CD3 BY LYMPHOBLASTIC LYMPHOMA
Authors: PILOZZI E PULFORD K JONES M MULLERHERMELINK HK FALINI B RALFKIAER E PILERI S PEZZELLA F DEWOLFPEETERS C ARBER D STEIN H MASON D GATTER K
Citation: E. Pilozzi et al., COEXPRESSION OF CD79A (JCB117) AND CD3 BY LYMPHOBLASTIC LYMPHOMA, Journal of pathology, 186(2), 1998, pp. 140-143
NPM-ALK EXPRESSION AS A DIAGNOSTIC MARKER IN CUTANEOUS CD30 POSITIVE T-CELL LYMPHOPROLIFERATIVE DISORDERS
Authors: TENBERGE RL OUDEJANS JJ PULFORD K WILLEMZE R MASON DY MEIJER CJLM
Citation: Rl. Tenberge et al., NPM-ALK EXPRESSION AS A DIAGNOSTIC MARKER IN CUTANEOUS CD30 POSITIVE T-CELL LYMPHOPROLIFERATIVE DISORDERS, Journal of investigative dermatology, 110(4), 1998, pp. 578-578
TAL1 EXPRESSION DOES NOT OCCUR IN THE MAJORITY OF T-ALL BLASTS
Authors: DELABESSE E BERNARD M MEYER V SMIT L PULFORD K CAYUELA JM RITZ J BOURQUELOT P STROMINGER JL VALENSI F MACINTYRE EA
Citation: E. Delabesse et al., TAL1 EXPRESSION DOES NOT OCCUR IN THE MAJORITY OF T-ALL BLASTS, British Journal of Haematology, 102(2), 1998, pp. 449-457
ALK-POSITIVE LYMPHOMA - A SINGLE DISEASE WITH A BROAD-SPECTRUM OF MORPHOLOGY
Authors: BENHARROCH D MEGUERIANBEDOYAN Z LAMANT L AMIN C BRUGIERES L TERRIERLACOMBE MJ HARALAMBIEVA E PULFORD K PILERI S MORRIS SW MASON DY DELSOL G
Citation: D. Benharroch et al., ALK-POSITIVE LYMPHOMA - A SINGLE DISEASE WITH A BROAD-SPECTRUM OF MORPHOLOGY, Blood, 91(6), 1998, pp. 2076-2084
CHARACTERIZATION OF T(2-5) RECIPROCAL TRANSCRIPTS AND GENOMIC BREAKPOINTS IN CD30(+) CUTANEOUS LYMPHOPROLIFERATIONS
Authors: BEYLOTBARRY M GROPPI A VERGIER B PULFORD K MERLIO JP
Citation: M. Beylotbarry et al., CHARACTERIZATION OF T(2-5) RECIPROCAL TRANSCRIPTS AND GENOMIC BREAKPOINTS IN CD30(+) CUTANEOUS LYMPHOPROLIFERATIONS, Blood, 91(12), 1998, pp. 4668-4676
ALK EXPRESSION DEFINES A DISTINCT GROUP OF T NULL LYMPHOMAS (ALK LYMPHOMAS) WITH A WIDE MORPHOLOGICAL SPECTRUM/
Authors: FALINI B BIGERNA B FIZZOTTI M PULFORD K PILERI SA DELSOL G CARBONE A PAULLI M MAGRINI U MENESTRINA F GIARDINI R PILOTTI S MEZZELANI A UGOLINI B BILLI M PUCCIARINI A PACINI R PELICCI PG FLENGHI L
Citation: B. Falini et al., ALK EXPRESSION DEFINES A DISTINCT GROUP OF T NULL LYMPHOMAS (ALK LYMPHOMAS) WITH A WIDE MORPHOLOGICAL SPECTRUM/, The American journal of pathology, 153(3), 1998, pp. 875-886
THE T(2-5)-ASSOCIATED P80 NPM ALK FUSION PROTEIN IN NODAL AND CUTANEOUS CD30+ LYMPHOPROLIFERATIVE DISORDERS/
Authors: SU LD SCHNITZER B ROSS CW VASEF M MORI S SHIOTA M MASON DY PULFORD K HEADINGTON JT SINGLETON TP
Citation: Ld. Su et al., THE T(2-5)-ASSOCIATED P80 NPM ALK FUSION PROTEIN IN NODAL AND CUTANEOUS CD30+ LYMPHOPROLIFERATIVE DISORDERS/, Journal of cutaneous pathology, 24(10), 1997, pp. 597-603
ROLE OF THE NUCLEOPHOSMIN (NPM) PORTION OF THE NON-HODGKINS LYMPHOMA-ASSOCIATED NPM-ANAPLASTIC LYMPHOMA KINASE FUSION PROTEIN IN ONCOGENESIS
Authors: BISCHOF D PULFORD K MASON DY MORRIS SW
Citation: D. Bischof et al., ROLE OF THE NUCLEOPHOSMIN (NPM) PORTION OF THE NON-HODGKINS LYMPHOMA-ASSOCIATED NPM-ANAPLASTIC LYMPHOMA KINASE FUSION PROTEIN IN ONCOGENESIS, Molecular and cellular biology, 17(4), 1997, pp. 2312-2325
ANAPLASTIC LARGE-CELL LYMPHOMA OF MATERNAL ORIGIN INVOLVING THE PLACENTA - CASE-REPORT AND LITERATURE SURVEY
Authors: MEGUERIANBEDOYAN Z LAMANT L HOPFNER C PULFORD K CHITTAL S DELSOL G
Citation: Z. Meguerianbedoyan et al., ANAPLASTIC LARGE-CELL LYMPHOMA OF MATERNAL ORIGIN INVOLVING THE PLACENTA - CASE-REPORT AND LITERATURE SURVEY, The American journal of surgical pathology, 21(10), 1997, pp. 1236-1241
PROGNOSTIC-SIGNIFICANCE OF P80 ALK1 EXPRESSION IN DIFFUSE LARGE-CELL LYMPHOMAS(DLCL)/
Authors: AUER I PULFORD K MASON DY STROUD D CONNORS JM GASCOYNE RD
Citation: I. Auer et al., PROGNOSTIC-SIGNIFICANCE OF P80 ALK1 EXPRESSION IN DIFFUSE LARGE-CELL LYMPHOMAS(DLCL)/, Laboratory investigation, 76(1), 1997, pp. 695-695
ALK-1 ANTIBODY STAINING PATTERN IN ANAPLASTIC LARGE-CELL LYMPHOMA (ALCL) AND ALCL-HODGKINS LIKE
Authors: PITTALUGA S PULFORD K WLODARSKA I MASON DY VANDENBERGHE H DEWOLFPEETERS C LEUVEN KU
Citation: S. Pittaluga et al., ALK-1 ANTIBODY STAINING PATTERN IN ANAPLASTIC LARGE-CELL LYMPHOMA (ALCL) AND ALCL-HODGKINS LIKE, Laboratory investigation, 76(1), 1997, pp. 768-768
EXPRESSION OF THE P80 NPM ALK FUSION PROTEIN IN ANAPLASTIC LYMPHOMA/
Authors: WOOD KM PARR A JACK F PULFORD K LESSELLS AM KRAJEWSKI AS LEVISON DA GOODLAD J THOMPSON WD LEE FD HOME CHW ANGUS B
Citation: Km. Wood et al., EXPRESSION OF THE P80 NPM ALK FUSION PROTEIN IN ANAPLASTIC LYMPHOMA/, Journal of pathology, 182, 1997, pp. 38-38
DIFFERENT PROGNOSIS BETWEEN CUTANEOUS AND SYSTEMIC CD30+ LYMPHOPROLIFERATIVE DISORDERS IS NOT SUPPORTED BY BIOLOGICAL DATA
Authors: BEYLOTBARRY M VERGIER B PULFORD K BOSQ MJ DEMURET A BEYLOT C DELAUNAY MM AVRIL MF DALAC S BODEMER C JOLY P BAGOT M DEMASCAREL A MANSON DY WECHSLER J MERLIO JP
Citation: M. Beylotbarry et al., DIFFERENT PROGNOSIS BETWEEN CUTANEOUS AND SYSTEMIC CD30+ LYMPHOPROLIFERATIVE DISORDERS IS NOT SUPPORTED BY BIOLOGICAL DATA, Journal of investigative dermatology, 109(3), 1997, pp. 484-484
THE PLASMA-CELL ASSOCIATED ANTIGEN DETECTABLE BY ANTIBODY VS38 IS THEP63 ROUGH ENDOPLASMIC-RETICULUM PROTEIN
Authors: BANHAM AH TURLEY H PULFORD K GATTER K MASON DY
Citation: Ah. Banham et al., THE PLASMA-CELL ASSOCIATED ANTIGEN DETECTABLE BY ANTIBODY VS38 IS THEP63 ROUGH ENDOPLASMIC-RETICULUM PROTEIN, Journal of Clinical Pathology, 50(6), 1997, pp. 485-489
RETROVIRUS-MEDIATED GENE-TRANSFER OF NPM-ALK CAUSES LYMPHOID MALIGNANCY IN MICE
Authors: KUEFER MU LOOK AT PULFORD K BEHM FG PATTENGALE PK MASON DY MORRIS SW
Citation: Mu. Kuefer et al., RETROVIRUS-MEDIATED GENE-TRANSFER OF NPM-ALK CAUSES LYMPHOID MALIGNANCY IN MICE, Blood, 90(8), 1997, pp. 2901-2910
A NEW SUBTYPE OF LARGE B-CELL LYMPHOMA EXPRESSING THE ALK KINASE AND LACKING THE 2-5-TRANSLOCATION
Authors: DELSOL G LAMANT L MARIAME B PULFORD K DASTUGUE N BROUSSET P RIGALHUGUET F ALSAATI T CERRETTI DP MORRIS SW MASON DY
Citation: G. Delsol et al., A NEW SUBTYPE OF LARGE B-CELL LYMPHOMA EXPRESSING THE ALK KINASE AND LACKING THE 2-5-TRANSLOCATION, Blood, 89(5), 1997, pp. 1483-1490
DETECTION OF ANAPLASTIC LYMPHOMA KINASE (ALK) AND NUCLEOLAR PROTEIN NUCLEOPHOSMIN (NPM)-ALK PROTEINS IN NORMAL AND NEOPLASTIC-CELLS WITH THE MONOCLONAL-ANTIBODY ALK1
Authors: PULFORD K LAMANT L MORRIS SW BUTLER LH WOOD KM STROUD D DELSOL G MASON DY
Citation: K. Pulford et al., DETECTION OF ANAPLASTIC LYMPHOMA KINASE (ALK) AND NUCLEOLAR PROTEIN NUCLEOPHOSMIN (NPM)-ALK PROTEINS IN NORMAL AND NEOPLASTIC-CELLS WITH THE MONOCLONAL-ANTIBODY ALK1, Blood, 89(4), 1997, pp. 1394-1404
THE MONOCLONAL-ANTIBODY ALK1 IDENTIFIES A DISTINCT MORPHOLOGICAL SUBTYPE OF ANAPLASTIC LARGE-CELL LYMPHOMA ASSOCIATED WITH 2P23 ALK REARRANGEMENTS/
Authors: PITTALUGA S WLODARSKA I PULFORD K CAMPO E MORRIS SW VANDENBERGHE H DEWOLFPEETERS C
Citation: S. Pittaluga et al., THE MONOCLONAL-ANTIBODY ALK1 IDENTIFIES A DISTINCT MORPHOLOGICAL SUBTYPE OF ANAPLASTIC LARGE-CELL LYMPHOMA ASSOCIATED WITH 2P23 ALK REARRANGEMENTS/, The American journal of pathology, 151(2), 1997, pp. 343-351
FREQUENT EXPRESSION OF THE NPM-ALK CHIMERIC FUSION PROTEIN IN ANAPLASTIC LARGE-CELL LYMPHOMA, LYMPHO-HISTIOCYTIC TYPE
Authors: PILERI SA PULFORD K MORI S MASON DY SABATTINI E RONCADOR G PICCIOLI M CECCARELLI C PICCALUGA PP SANTINI D LEONE O STEIN H FALINI B
Citation: Sa. Pileri et al., FREQUENT EXPRESSION OF THE NPM-ALK CHIMERIC FUSION PROTEIN IN ANAPLASTIC LARGE-CELL LYMPHOMA, LYMPHO-HISTIOCYTIC TYPE, The American journal of pathology, 150(4), 1997, pp. 1207-1211
AN IMMUNOHISTOCHEMICAL STUDY OF TAL-1 PROTEIN EXPRESSION IN LEUKEMIASAND LYMPHOMAS WITH A NOVEL MONOCLONAL-ANTIBODY, 2TL-242
Authors: CHETTY R PULFORD K JONES M MATHIEUMAHUL D CLOSE P HUSSEIN S PALLESEN G RALFKIAER E STEIN H GATTER K MASON D
Citation: R. Chetty et al., AN IMMUNOHISTOCHEMICAL STUDY OF TAL-1 PROTEIN EXPRESSION IN LEUKEMIASAND LYMPHOMAS WITH A NOVEL MONOCLONAL-ANTIBODY, 2TL-242, Journal of pathology, 178(3), 1996, pp. 311-315
TAL-1 EXPRESSION DOES NOT OCCUR IN THE MAJORITY OF T-ALL BLASTS
Authors: DELABESSE E BERNARD M MEYER V SMIT L PULFORD K LANDMANPARKER J STROMINGER JL VARET B VALENSI F MACINTYRE E
Citation: E. Delabesse et al., TAL-1 EXPRESSION DOES NOT OCCUR IN THE MAJORITY OF T-ALL BLASTS, Blood, 88(10), 1996, pp. 296-296
EXPRESSION OF THE TAL1 PROTEIN IN AML - CORRELATION WITH MORPHOLOGY, IMMUNOPHENOTYPE, MOLECULAR-GENETICS AND PROGNOSIS
Authors: BOURQUELOT PM MEYER V DELABESSE E BERNARD M PULFORD K GARAND R IMBERT M VALENSI F VAREL B FLANDRIN G MACINTYRE EA
Citation: Pm. Bourquelot et al., EXPRESSION OF THE TAL1 PROTEIN IN AML - CORRELATION WITH MORPHOLOGY, IMMUNOPHENOTYPE, MOLECULAR-GENETICS AND PROGNOSIS, Blood, 88(10), 1996, pp. 2251-2251
IMMUNOCYTOCHEMICAL DISTRIBUTION OF THE CDW75 ANTIGEN
Authors: PULFORD K JONES M STROUD D MASON DY
Citation: K. Pulford et al., IMMUNOCYTOCHEMICAL DISTRIBUTION OF THE CDW75 ANTIGEN, Tissue antigens, 48(4-II), 1996, pp. 409-409
Risultati: 1-25 | 26-39